Localized Cutaneous Leishmaniasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-05-30
Clinical Trial Update: A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR). [Phase 2]
A Phase 2 clinical trial is evaluating two LXE408 oral regimens versus miltefosine as an active control to assess efficacy, safety, and phar…